Extended interval BNT162b2 vaccination enhances peak antibody generation in older people
Pending peer review, but apparently large benefit in waiting 12 weeks rather than three.
In donors without evidence of previous infection the peak antibody response was 3.5-fold higher in donors who had undergone delayed interval vaccination. Cellular immune responses were 3.6-fold lower.